Compositions and methods for delivering cyclin-dependent kinase-like 5 protein
TW202635894APending Publication Date: 2026-09-01NEUROCRINE BIOSCIENCES INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114141929
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-30
- Filing Date
- 2025-10-29
- Publication Date
- 2026-09-01
Smart Images
Figure TWG2TA001074534_001 
Figure TWG2TA001074534_002 
Figure TWG2TA001074534_003
Abstract
(CDKL5) proteins and peptides, compositions comprising said AAV particles, and methods for making and delivering said AAV particles to a cell or subject. The AAV particles, compositions, and methods of the present disclosure are useful for the treatment of subjects who have, have been diagnosed with having, or are at risk of having a CDKL5 deficiency disorder (CDD), developmental and epileptic encephalopathy
Need to check novelty before this filing date? Find Prior Art